Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: Adamis pharmaceuticals | Vintage Vibes

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Benzinga · Oct 13, 2022

Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic alternatives.

Benzinga · Oct 12, 2022

Recap Of Friday's Biotech Catalysts - End of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Benzinga · Jul 29, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Adamis Pharmaceuticals's Return On Capital Employed Overview

Adamis Pharmaceuticals (NASDAQ:ADMP) brought in sales totaling $1.16 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 18.01%, resulting in a loss of $10.35 million.

Benzinga · Jun 22, 2022

Adamis Pharmaceuticals's Earnings Outlook

Adamis Pharmaceuticals (NASDAQ:ADMP) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Adamis Pharmaceuticals will report an earnings per share (EPS) of $-0.04.

Benzinga · Mar 30, 2022

Adamis Pharma Recalls Allergy Treatment Symjepi For Potential Manufacturing Defect

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) voluntarily recalls certain lots of Symjepi (epinephrine) Injection 0.15 mg and 0.3 mg pre-filled single-dose syringes to the consumer level. The batches are being recalled due to the potential clogging of the needle preventing the dispensing of epinephrine. US WorldMeds (USWM) exclusively markets and distributes Symjepi in the U.S.,…

Benzinga · Mar 22, 2022

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.

Benzinga · Mar 21, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Benzinga

Organisations

US Food and Drug Administration

Enanta Pharmaceuticals

11 stories

Meridian Bioscience

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

430,308 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.